Thoraxklinik - Heidelberg gGmbH
- Country
- 🇩🇪Germany
- Ownership
- Private, Subsidiary
- Employees
- 501
- Market Cap
- -
Clinical Trials
14
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
EBUS Guided Cryobiopsies With Ultrathin Cryoprobe in Patients With Peripheral Pulmonary Nodules - a Feasibility Study
- Conditions
- Transbronchial Cryobiopsy
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2020-10-12
- Lead Sponsor
- Thoraxklinik-Heidelberg gGmbH
- Target Recruit Count
- 34
- Registration Number
- NCT04471324
- Locations
- 🇩🇪
Thoraxklinik Universitaetsmedizin, Heidelberg, Baden-Wuerttemberg, Germany
Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC
- Conditions
- EGFR Positive Non-small Cell Lung Cancer
- First Posted Date
- 2019-09-26
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Thoraxklinik-Heidelberg gGmbH
- Target Recruit Count
- 400
- Registration Number
- NCT04105153
- Locations
- 🇩🇪
Thoraxklinik-Heidelberg gGmbH - Universitätsklinikum Heidelberg, Heidelberg, Germany
Trial on Refinement of Early Stage Lung Cancer Adjuvant Therapy
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2006-07-06
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Thoraxklinik-Heidelberg gGmbH
- Target Recruit Count
- 132
- Registration Number
- NCT00349089
- Locations
- 🇧🇪
Ziekenhuis Oost Limburg, Genk, Belgium
🇧🇪Department of Pulmonology (Respiratory Tumor Unit), University Hospital Gasthuisberg, Catholic University Leuven, Belgium., Leuven, Belgium
🇩🇪Helios-Klinikum Emil von Behring, Berlin, Germany